Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$30.1

Avg closing price
Price range

3 First Eagle Investments Theravance Biopharma Trades

First Eagle Investments started to build up the position in Theravance Biopharma in Q2 2014. Since then they sold 456 Thousand shares. The investor completely sold their stake between Q3 2014 and Q4 2014.

Avg closing price
Price range
Sold -455 Thousand shares Q4 2014
Avg closing price $17.41
Price range $13.33 - $23.19
Sold 0.1% shares (-532 shares) Q3 2014
Avg closing price $29.02
Price range $23.05 - $33.99
New holding (+456 Thousand shares) Q2 2014
Avg closing price $30.10
Price range $23.51 - $34.87

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!